Content area
Full Text
Gambro AB, Stockholm, Sweden, (OM Stockholm Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, is substantially expanding the deliveries of dialyzers. Gambro has also announced major investments in further production capacity of synthetic dialyzers in Germany.
The demand for Gambro's advanced synthetic hollow fiber Polyflux dialyzer is increasing substantially. To meet this demand Gambro is increasing the output this year and the next in order to reach an extra capacity of almost 1.5 million dialyzers annually. The synthetic Polyflux dialyzer has been launched in the US for single use autumn 1999 and is planned to be introduced also for reuse. Clinical testing has showed superior performance and approval is expected during the spring this year.
Investments are also made in substantial new capacity for production of next generation Polyflux dialyzers in Germany. At the production site in Hechingen the building of new production lines for dialyzers was initiated today, February 11, 2000. This new capacity includes the new Polyflux synthetic dialyzers based on common technology platforms. The new capacity exceeds 5 million dialyzers annually. Deliveries will start late next year. Further expansion in production of synthetic...